Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 059717/0217 | |
| Pages: | 7 |
| | Recorded: | 04/18/2022 | | |
Conveyance: | CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
3
|
|
Patent #:
|
|
Issue Dt:
|
05/31/2022
|
Application #:
|
16098615
|
Filing Dt:
|
11/02/2018
|
Publication #:
|
|
Pub Dt:
|
05/16/2019
| | | | |
Title:
|
Formulation Containing TLR Agonist and Methods of Use
|
|
|
Patent #:
|
|
Issue Dt:
|
06/28/2022
|
Application #:
|
16126285
|
Filing Dt:
|
09/10/2018
|
Publication #:
|
|
Pub Dt:
|
02/06/2020
| | | | |
Title:
|
Compositions and Methods for Treating an Active Mycobacterium Tuberculosis Infection
|
|
|
Patent #:
|
|
Issue Dt:
|
07/05/2022
|
Application #:
|
16899729
|
Filing Dt:
|
06/12/2020
|
Publication #:
|
|
Pub Dt:
|
12/03/2020
| | | | |
Title:
|
METHOD OF INDUCING AN IMMUNE RESPONSE USING AN EXPRESSION CONSTRUCT AND GLA
|
|
Assignee
|
|
|
1616 EASTLAKE AVENUE E., SUITE 400 |
SEATTLE, WASHINGTON 98102 |
|
Correspondence name and address
|
|
NEWPORT IP, LLC
|
|
1400 112TH AVE SE, SUITE 100
|
|
BELLEVUE, WA 98004
|
Search Results as of:
06/23/2024 12:06 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|